Oncology Letters · 2017 · 17 citations · 24 references
MedicineCancer BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionCancer Cell SignalingCancer EtiologyCancer ProgressionMalignant NeoplasmsNasopharyngeal CancerNoncoding Rna In CancerAssayCell Growth RegulationLuciferase Reporter AssaysLuciferase ReportersMicrorna In CancerProtein Expression LevelsReverse Transcription Polymerase Chain Reaction (Rt-pcr)Western Blot Analysis
Nasopharyngeal carcinoma (NPC) is an epithelial malignancy of the head and neck with the highest incidence rate in southern China. The aim of the present study was to understand the molecular mechanisms that underlie the progression of NPC. The relative expression of miR-93 and CDKN1A was detected by the reverse-transcription quantitative PCR. Western blot analysis was applied to detect the protein levels of genes. Luciferase activity report was applied to verify the target of miRNA. Cell growth was assayed by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. miR-93 was upregulated in NPC tissues and cell lines compared with normal samples. Re-expression of miR-93 promoted cell growth in vitro as determined by the MTT assay. CDKN1A was identified by luciferase reporter as a direct target of miR-93. Its expression was downregulated by miR-93. Furthermore, the results showed that the expression of miR-93 was inversely correlated with the expression of CDKN1A protein. miR-93 enhanced cell proliferation in NPC by directly targeting CDKN1A. It is suggested that miR-93/CDKN1A axis may present a new target for the treatment of NPC.
24
Shu-zhen Lai, Wen‐Fei Li, Lei Chen et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 620 citations